Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy

Urological Research

Volumn 41, Issue 3, 2013, Pages 247-252

  Lee, Yuan Ju ^a,b   Huang, Kuo How ^a   Yang, Hung Ju ^a   Chang, Hong Chiang ^a   Chen, Jun ^a   Yang, Teng Kai ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Lower urinary tract symptoms; Solifenacin; Ureteral stent

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; MUSCARINIC RECEPTOR BLOCKING AGENT; PARACETAMOL; POLYURETHAN; SOLIFENACIN; QUINUCLIDINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; URINARY TRACT AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DOUBLE J STENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HEMATURIA; HOLMIUM LASER; HUMAN; LANGUAGE; LITHOTRIPSY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT OUTCOME; URETER STENT; URETERAL SYMPTOM SCORE QUESTIONNAIRE; URETEROSCOPIC LITHOTRIPSY; URETEROSCOPY; URINE RETENTION; XEROSTOMIA; ADVERSE EFFECTS; AGED; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; STENT; URETERAL CALCULI; URETERAL OBSTRUCTION; URETER OBSTRUCTION; URETER STONE; DISEASE SEVERITY; DRUG EFFECT; DRUG TOLERABILITY; FLANK PAIN; GENDER; MEDICAL DEVICE COMPLICATION; URETHRAL PAIN; URGE INCONTINENCE;

ADULT; AGED; FEMALE; HEMATURIA; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PAIN; PROSPECTIVE STUDIES; QUINUCLIDINES; SOLIFENACIN SUCCINATE; STENTS; TETRAHYDROISOQUINOLINES; URETERAL CALCULI; URETERAL OBSTRUCTION; URETEROSCOPY; UROLOGICAL AGENTS;

EID: 84891721130     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-013-0554-y     Document Type: Article

References (23)

1. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169: 1065-1069 (discussion 1069)
2. Sighinolfi MC, Micali S, De Stefani S, Mofferdin A, Grande M, Giacometti M, Ferrari N, Rivalta M, Bianchi G (2007) Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol 178:229-231
3. Damiano R, Autorino R, De Sio M, Cantiello F, Quarto G, Perdona S, Sacco R, D'Armiento M (2005) Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 48:673-678
4. Thomas R (1993) Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol 7:137-140
5. Park SC, Jung SW, Lee JW, Rim JS (2009) The effects of tolterodine extended release and alfuzosin for the treatment of double-J stent-related symptoms. J Endourol 23:1913-1917
6. Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D'Armiento M (2008) Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22: 651-656
7. Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181: 170-176
8. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P (2011) Is there a role for alpha-blockers in ureteral stent related symptoms? A systematic review and meta-Analysis. J Urol 186:928-934
9. Vardy MD, Mitcheson HD, Samuels TA, Wegenke JD, Forero-Schwanhaeuser S, Marshall TS, He W (2009) Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT-A double-blind, placebo-controlled trial. Int J Clin Pract 63:1702-1714
10. Ho CH, Chang TC, Lin HH, Liu SP, Huang KH, Yu HJ (2010) Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms. J Formos Med Assoc 109: 702-708
11. Lim KT, Kim YT, Lee TY, Park SY (2011) Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 52:485-488
12. Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG (2003) Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169:1060-1064
13. Gunlusoy B, Degirmenci T, Arslan M, Kozacyoglu Z, Minareci S, Ayder AR (2008) Is ureteral catheterization necessary after ureteroscopic lithotripsy for uncomplicated upper ureteral stones? J Endourol 22:1645-1648
14. Chen YT, Chen J, Wong WY, Yang SS, Hsieh CH, Wang CC (2002) Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial. J Urol 167:1977-1980
15. Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM (2006) Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 67:35-39
16. Gupta M, Patel T, Xavier K, Maruffo F, Lehman D, Walsh R, Landman J (2010) Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. J Urol 183:598-602
17. Joshi HB, Chitale SV, Nagarajan M, Irving SO, Browning AJ, Biyani CS, Burgess NA (2005) A prospective randomized singleblind comparison of ureteral stents composed of firm and soft polymer. J Urol 174:2303-2306
18. Candela JV, Bellman GC (1997) Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol 11:45-47
19. Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J (2005) A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 48:464-470
20. Herschorn S, Stothers L, Carlson K et al (2010) Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial. J Urol 183:1892-1898
21. van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179-183
22. Osman Y, El-Tabey N, Refai H, Elnahas A, Shoma A, Eraky I, Kenawy M, El-Kapany H (2008) Detection of residual stones after percutaneous nephrolithotomy: role of nonenhanced spiral computerized tomography. J Urol 179:198-200 discussion 200
23. Park J, Hong B, Park T, Park HK (2007) Effectiveness of noncontrast computed tomography in evaluation of residual stones after percutaneous nephrolithotomy. J Endourol 21:684-687